[
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific (NYSE:TMO) Partners With Cybin For Phase 3 Depression Treatment",
    "summary": "Thermo Fisher Scientific (NYSE:TMO) recently partnered with Cybin Inc. to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, a promising treatment for Major Depressive Disorder. Despite this partnership news, the company's stock price was flat last week, in contrast to a positive broader market trend marked by a 5.1% rise. Factors such as the overall market sentiment driven by strong economic data and earnings reports likely influenced stock movements more...",
    "url": "https://finnhub.io/api/news?id=f35fef676ccc746dd8b121743dfa1d2279a8c67676d75b753bb10e70316751a2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747330306,
      "headline": "Thermo Fisher Scientific (NYSE:TMO) Partners With Cybin For Phase 3 Depression Treatment",
      "id": 134483700,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific (NYSE:TMO) recently partnered with Cybin Inc. to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, a promising treatment for Major Depressive Disorder. Despite this partnership news, the company's stock price was flat last week, in contrast to a positive broader market trend marked by a 5.1% rise. Factors such as the overall market sentiment driven by strong economic data and earnings reports likely influenced stock movements more...",
      "url": "https://finnhub.io/api/news?id=f35fef676ccc746dd8b121743dfa1d2279a8c67676d75b753bb10e70316751a2"
    }
  },
  {
    "ts": null,
    "headline": "Cybin Inc. Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for Its Cyb003 Program for the Adjunctive Treatment of Major Depressive Disorder",
    "summary": "Cybin Inc. announced that it has engaged Thermo Fisher Scientific , to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, the Company's proprietary deuterated...",
    "url": "https://finnhub.io/api/news?id=40942aa586a0edf646113ca23914455c6f246a4889d9463731331b916d75b7ed",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747294200,
      "headline": "Cybin Inc. Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for Its Cyb003 Program for the Adjunctive Treatment of Major Depressive Disorder",
      "id": 134466502,
      "image": "",
      "related": "TMO",
      "source": "Finnhub",
      "summary": "Cybin Inc. announced that it has engaged Thermo Fisher Scientific , to support the Phase 3 clinical supply and potential commercial manufacturing of CYB003, the Company's proprietary deuterated...",
      "url": "https://finnhub.io/api/news?id=40942aa586a0edf646113ca23914455c6f246a4889d9463731331b916d75b7ed"
    }
  }
]